date:Oct 04, 2012
reports recommendations
Regarding the recommendations, Mister said CRN was very supportive of FDA to do more, especially when it came keeping better track of health claim notifications, which companies are supposed to send in 30 days prior to a product hitting the market. But the first recommendation, calling for FDA to seek statutory authority to review substantiation for structure/function claims to determine whether they are truthful and not misleading, is a non-starter, he said.
This sound